Hostname: page-component-8448b6f56d-mp689 Total loading time: 0 Render date: 2024-04-16T18:28:38.669Z Has data issue: false hasContentIssue false
  • English
  • Français

Impact of Nosocomial Infection on Cost of Illness and Length of Stay in Intensive Care Units

Published online by Cambridge University Press:  21 June 2016

Yin-Yin Chen ,
Yi-Chang Chou  and
Pesus Chou
Yin-Yin Chen
Affiliation:
Committee of Nosocomial Infection Control, Taipei Veterans General Hospital, Taipei, Taiwan, Republic of China
Yi-Chang Chou
Affiliation:
Community Medicine Research Center & Institute of Public Health, National Yang-Ming University, Taipei, Taiwan, Republic of China
Pesus Chou*
Affiliation:
Community Medicine Research Center & Institute of Public Health, National Yang-Ming University, Taipei, Taiwan, Republic of China
*
National Yang-Ming University, Institute of Public Health, Shih-Pai, Taipei, 112, Taiwanpschou@ym.edu.tw
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

Economic evaluation has become increasingly important in healthcare and infection control. This study evaluated the impact of nosocomial infections on cost of illness and length of stay (LOS) in intensive care units (ICUs).

Design:

A retrospective cohort study.

Setting:

Medical, surgical, and mixed medical and surgical ICUs in a tertiary-care referral medical center.

Patients:

Patients admitted to adult ICUs between October 2001 and June 2002 were eligible for the study.

Methods:

Estimates of the cost and LOS for patients who acquired a nosocomial infection were computed using a stratified analysis and regression approach.

Results:

During the study period, 778 patients were admitted to the ICUs. Total costs for patients with and without nosocomial infections (median cost, $10,354 and $3,985, respectively) were significantly different (P < .05). The costs stratified by infection site (median differences from $4,687 to $7,365) and primary diagnosis (median differences from $5,585 to $16,507) were also significantly different (P < .05) except for surgical-site infection. After covariates were adjusted for in the multiple linear regression, nosocomial infection increased the total costs by $3,306 per patient and increased the LOS by 18.2 days per patient (P < .001). Each additional day spent in the ICU increased the cost per patient by $353 (P < .001).

Conclusions:

Nosocomial infections are associated with increased cost of illness and LOS. Prevention of nosocomial infections should reduce direct costs and decrease the LOS.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 26 , Issue 3 , March 2005 , pp. 281 - 287
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Horan, T, Saint, S, Saint, S, Chenoweth, C, Fendrick, AM. The role of economic evaluation in infection control. Am J Infect Control 2001;29:338–344.CrossRefGoogle Scholar
2.Jarvis, WR. Selected aspects of the socioeconomic impact of nosocomial infections: morbidity, mortality, cost, and prevention. Infect Control Hosp Epidemiol 1996;17:552–557.CrossRefGoogle ScholarPubMed
3.Haley, RW. Cost-benefit analysis of infection control programs. In: Bennett, JV, Brachman, PS, eds. Hospital Infections, ed. 4. Philadelphia: Lippincott-Raven; 1998:249–267.Google Scholar
4.Mundy, LM, Fraser, VJ. Determining the cost-effectiveness of hospital epidemiology and infection control programs. In: Mayhall, CG, ed. Hospital Epidemiology and Infection Control, ed. 2. Philadelphia: Lippincott Williams & Wilkins; 1999:1437–1443.Google Scholar
5.Haley, RW, White, JW, Culver, DH, Hughes, JM. The financial incentive for hospitals to prevent nosocomial infections under the prospective payment system: an empirical determination from a nationally representative sample. JAMA 1987;257:1611–1614.Google Scholar
6.Heyland, DK, Gafni, A, Kernerman, P, Keenan, S, Chalfin, D. How to use the results of an economic evaluation. Crit Care Med 1999;27:1195–1202.Google Scholar
7.Esserman, L, Belkora, J, Lenert, L. Potentially ineffective care: a new outcome to assess the limits of critical care. JAMA 1995;274:1544–1551.Google Scholar
8.Centers for Disease Control and Prevention National Nosocomial Infections Surveillance (NNIS) System. National Nosocomial Infections Surveillance (NNIS) System report: data summary from January 1992-April 2000. Am J Infect Control 2000;28:449–453.Google Scholar
9.Stone, PW, Larson, E, Kawar, LN. A systematic audit of economic evidence linking nosocomial infections and infection control interventions: 1990-2000. Am J Infect Control 2002;30:145–152.Google Scholar
10.Vincent, JL, Bihari, DJ, Suter, PM, et al.The prevalence of nosocomial infection in intensive care units in Europe: results of the European Prevalence of Infection in Intensive Care (EPIC) study. JAMA 1995; 274:639–644.Google Scholar
11.Pittet, D, Harbarth, SJ. The intensive care unit. In: Bennett, JV, Brachman, PS, eds. Hospital Infections, ed. 4. Philadelphia: Lippincott Raven; 1998:381–402.Google Scholar
12.Wenzel, RP. The Lowbury Lecture: the economics of nosocomial infections. J Hosp Infect 1995;31:79–87.CrossRefGoogle ScholarPubMed
13.Digiovine, B, Chenoweth, C, Watts, C, Higgins, M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 1999;160:976–981.CrossRefGoogle ScholarPubMed
14.Dominguez, TE, Chalom, R, Costarino, AT Jr. The impact of adverse patient occurrences on hospital costs in the pediatric intensive care unit. Crit Care Med 2001;29:169–174.Google Scholar
15.Slonim, AD, Singh, N. Nosocomial bloodstream infection and cost. Crit Care Med 2001;29:1849.Google Scholar
16.Diaz, MC, Garcia, MM, Bueno, CA, Lopez, LA, Delgado, RM, Galvez, VR. The estimation of the cost of nosocomial infection in an intensive care unit. Med Clin (Bare) 1993;100:329–332.Google Scholar
17.Miller, ZC. Excess length of stay, charges, and mortality attributable to medical injuries during hospitalization. JAMA 2003;290:1868–1874.Google Scholar
18.Nelson, RM, Dries, DJ. The economic implications of infection in cardiac surgery. Ann Thorac Surg 1986;42:240–246.Google Scholar
19.Khan, MM, Celik, Y. Cost of nosocomial infection in Turkey: an estimate based on the university hospital data. Health Services Management Research 2001;4:49–54.Google Scholar
20.Orsi, GB, Di Stefano, LD, Noah, N. Hospital-acquired, laboratory-confirmed bloodstream infection: increased hospital stay and direct costs. Infect Control Hosp Epidemiol 2002;23:190–197.CrossRefGoogle ScholarPubMed
21.Whitehouse, JD, Friedman, ND, Kirkland, KB, Richardson, WJ, Sexton, DJ. The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol 2002;23:183–189.Google Scholar
22.Slonim, AD, Kurtines, HC, Sprague, BM, et al.The costs associated with nosocomial bloodstream infections in the pediatric intensive care unit. Pediatric Critical Care Medicine 2001;2:170–174.Google Scholar
23.Hollenbeak, CS, Murphy, D, Dunagan, WC, Fraser, VJ. Nonrandom selection and the attributable cost of surgical-site infections. Infect Control Hosp Epidemiol 2002;23:177–182.Google Scholar
24.The Hospital Infection Control Practices Advisory Committee. Recommendations for prevention of nosocomial intravascular device-related infections. Am J Infect Control 1996;24:277–293.Google Scholar
25.Garner, JS, Jarvis, WR, Emori, TG, Horan, TC. Hughes, JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16:128–140.CrossRefGoogle ScholarPubMed
26.Mangram, AJ, Horan, TC, Pearson, ML, Silver, LC, Jarvis, WR. Guideline for prevention of surgical site infection, 1999. Am J Infect Control 1999; 27:97–133.Google Scholar
27.Udvarhelyi, IS, Colditz, GA, Epstein, AM. Cost-effectiveness and cost-benefit analyses in the medical literature: are the methods being used correctly? Ann Intern Med 1992;116:238–244.Google Scholar
28.Haley, RW. Measuring the costs of nosocomial infections: methods for estimating economic burden on the hospital. Am J Med 1991;91:32S–38S.Google Scholar
29.Wey, SB, Mori, M, Pfaller, MA, Woolson, RF, Wenzel, RP. Hospital-acquired candidemia: the attributable mortality and excess length of stay. Arch Intern Med 1988;148:2642–2645.CrossRefGoogle ScholarPubMed